Oklahoma 2022 Regular Session

Oklahoma House Bill HB3971 Latest Draft

Bill / Enrolled Version Filed 05/20/2022

                            An Act 
ENROLLED HOUSE 
BILL NO. 3971 	By: Burns, West (Josh) and 
McDugle of the House  
 
  and 
 
  Leewright of the Senate  
 
 
 
 
 
 
An Act relating to medical marijuana; authorizing the 
Oklahoma Medical Marijuana Au thority to employ secret 
shoppers for certain purpose; directing secret 
shoppers to purchase specific amounts for compliance 
tests; providing guidelines for testing samples; 
directing secret shoppers to deliver samples to 
quality assurance laboratories for certain testing; 
directing the Authority to annually inspect minimum 
number of licensed medical marijuana di spensaries; 
providing for the recall of medical marijuana and 
marijuana products for safety failures; providing for 
the verification of certain laboratory results; 
requiring the retention of investigative results for 
certain number of years; directing the Authority to 
implement rules for providing certain notice; 
authorizing the Authority to take cer tain 
disciplinary actions; allowing the Authority to share 
investigative results with certain entities; 
authorizing the Authority to conduct fur ther 
evaluation of investigative results; prov iding for 
the revocation of business licenses under certain 
circumstances; directing the Authority to implement 
certain rules; providing for codification; and 
providing an effective date. 
 
 
 
 
SUBJECT: Medical marijuana 
 
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA: 
  ENR. H. B. NO. 3971 	Page 2 
SECTION 1.     NEW LAW     A new section of law to be codified 
in the Oklahoma Statutes as Section 427.25 of Title 63, unless there 
is created a duplication in numbering, reads as follows: 
 
A.  The Oklahoma Medical Marijuana Authority shall implement 
rules to employ secret shoppers. Secret shoppers shall purchase 
medical marijuana or marijuana products from licensed medical 
marijuana dispensaries. 
 
B. For each purchase, the secret shopper shall buy an amount of 
medical marijuana or marijuana products sufficient for five complete 
compliance tests. Four samples shall be tested by licensed medical 
marijuana testing laboratories, one of which shall be the laboratory 
of origin, if applicable .  One sample shall be kept in reserve by 
the Authority in the event of a discrepancy be tween the testing 
laboratories, which may require retesting of the medical marijuana 
or marijuana products. When making purchases from a licensed 
medical marijuana di spensary, the secret shopper shall ask for the 
certificate of analysis for each product purchased. 
 
C. The secret shopper shall deliver the medical marijuana or 
marijuana products to a quality assurance laboratory for 
homogenization. Once the samples have been homogenized, the samples 
shall be delivered to four randomly selected licensed medical 
marijuana testing laboratories for compliance testing which shall 
include the testing for pesticides, heavy metals, microbials, 
residual solvents for extracted products , and potency.  One sample 
shall be kept by the Authority in reserve. If the medical marijuana 
or marijuana products were previously tested with available results 
from a licensed medical marijuana testing laboratory, that testing 
laboratory shall be one of the four licensed medical marijuana 
testing laboratories chosen by the Authority. For the avoidance of 
doubt, neither the licensed medical marijuana dispensary nor the 
licensed medical marijuana testing laboratory shall be told that the 
business entity is selling medical marijuana or marijuana products 
to a secret shopper or testing samples submitted by a secret shopper 
employed by the Authority and posing as a licensed medical marijuana 
patient.  
 
D. The Authority shall inspect, by secret shopper, a minimum of 
fifty licensed medical marijuana dispensaries annually beginning 
January 1, 2024.  In the year 2025, the Authority shall inspect, by 
secret shopper, a minimum of ten percent (10%) of randomly selected 
licensed medical marijuana dispensaries in Oklahoma per year.  
  ENR. H. B. NO. 3971 	Page 3 
E. 1.  When the licensed medical marijuana testing laboratories 
unanimously confirm test results with safety failures for 
contaminants, the Authority shall recall the medical marijuana or 
marijuana product within seven (7) days of obtaining the test 
results. The name of the licensed medical marijuana dispensary and 
any other relevant product information shall be made public via a 
press release issued by the Authority. If there is greater than one 
but less than four contaminant fails among the licensed medical 
marijuana testing laborator ies, the Authority shall work with a 
quality assurance laboratory to verify the results of the licensed 
medical marijuana testing laboratories and take appropriate action. 
 
2.  When the average of total potency or total terpene re sults 
collected from a licensed medical marij uana testing laboratory for a 
particular product is outside the allowable limits, the Authority 
shall work with a quality assurance laboratory to verify the results 
of the testing laboratory. If results are verified to be outside 
the allowable limits, the Authority shall require relabeling of the 
medical marijuana or marijuana products. 
 
3. All investigative results shall be retained by the Authority 
for a minimum of three (3) years. 
 
4.  The Authority shall implement rules to notify any licensed 
medical marijuana dispensary and licensed medical marijuana grower 
or licensed medical marijuana processor of any investigative results 
determined to be noncompliant. 
 
5.  After the licensed medical marij uana dispensary and licensed 
medical marijuana grower or lic ensed medical marijuana processor is 
notified of the investigative results, such results may be used by 
the Authority to take action against the lice nsee, assess fines, or 
assess other civil penalties available to the Authority. 
 
6.  The Authority shall implement rules on shar ing such 
investigative results with any other l aw enforcement agencies or 
regulatory authorities. 
 
7. The Authority may elect to conduct further evaluations of 
the investigative results at any time fo r verification or for other 
purposes reasonably related to sanitation, p ublic health, or public 
safety.    
  ENR. H. B. NO. 3971 	Page 4 
F. The failure of any licensed medical marijuana business to 
cooperate with the provisions of this section may result in the 
revocation of the license at the discretion of the Authority. 
 
G.  The Authority shall implement rules necessary to enforce the 
provisions of this act. 
 
SECTION 2.  This act shall become effecti ve January 1, 2024. 
 
  ENR. H. B. NO. 3971 	Page 5 
 
Passed the House of Representatives the 19th day of May, 2022. 
 
 
 
  
 	Presiding Officer of the House 
 	of Representatives 
 
 
Passed the Senate the 20th day of May, 2022. 
 
 
 
  
 	Presiding Officer of the Senate 
 
 
 
OFFICE OF THE GOVERNOR 
Received by the Office of the Governor this ____________________ 
day of ___________________, 20_______, at _______ o'clock _______ M. 
By: _________________________________ 
Approved by the Governor of the State of Oklahoma this ____ _____ 
day of ___________________, 20_______, at _______ o'clock _______ M. 
 
 
 	_________________________________ 
 	Governor of the State of Oklahoma 
 
OFFICE OF THE SECRETARY OF STATE 
Received by the Office of the Secretary of State this __________ 
day of ___________________, 20_______, at _______ o'clock _______ M. 
By: _________________________________